Stock AKLI AKILI, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Akili, Inc.

Equities

AKLI

US00974B1070

Real-time Estimate Cboe BZX
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
0.431 USD +6.16% Intraday chart for Akili, Inc. -0.68% -16.65%
04-30 Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product CI
04-30 Akili, Inc. to Reduce Workforce CI

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
AKILI, INC. Stock Akili, Inc.
-16.65% 34.93M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+11.73% 221B
B
DANAHER CORPORATION Stock Danaher Corporation
+9.53% 186B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+14.63% 137B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+27.47% 109B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.04% 63.09B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.73% 52.68B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.86% 50.86B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+7.72% 42.53B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+7.86% 37.76B -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. AKLI Stock
  4. Ratings Akili, Inc.